Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status

Following the success of cancer immunotherapy using large molecules against immune checkpoint inhibitors, the concept of using small molecules to interfere with intracellular negative regulators of anti-tumor immune responses has emerged in recent years. The main targets for small molecule drugs cur...

Full description

Bibliographic Details
Main Authors: Lisa Schlicher, Luke G. Green, Andrea Romagnani, Florian Renner
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1297175/full